Inhaler
Latest CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. Patents:
- Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof
- Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine
- Steroid derivative FXR agonist
- Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases
- Borate of azetidine derivative
Description
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
D739522 | September 22, 2015 | Von Schuckmann |
D744087 | November 24, 2015 | Bilgic |
D789517 | June 13, 2017 | Bhide |
D816208 | April 24, 2018 | Bhide |
D831190 | October 16, 2018 | Von Schuckmann |
D847973 | May 7, 2019 | Haeger |
D849927 | May 28, 2019 | Von Schuckmann |
D855792 | August 6, 2019 | Toksoz |
D869636 | December 10, 2019 | Castellucci |
20140318538 | October 30, 2014 | Bilgic |
20160375207 | December 29, 2016 | Bhide |
20170056608 | March 2, 2017 | McDerment |
71015 | June 2009 | RU |
94174 | July 2015 | RU |
97713 | April 2016 | RU |
Patent History
Patent number: D888931
Type: Grant
Filed: Oct 4, 2018
Date of Patent: Jun 30, 2020
Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (Lianyungang)
Inventors: Changhui Li (Lianyungang), Xuebing Zhu (Lianyungang), Liping Zhou (Lianyungang)
Primary Examiner: Sheryl Lane
Assistant Examiner: Aula Soroush
Application Number: 29/665,588
Type: Grant
Filed: Oct 4, 2018
Date of Patent: Jun 30, 2020
Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (Lianyungang)
Inventors: Changhui Li (Lianyungang), Xuebing Zhu (Lianyungang), Liping Zhou (Lianyungang)
Primary Examiner: Sheryl Lane
Assistant Examiner: Aula Soroush
Application Number: 29/665,588
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)